Successful Intratracheal Treatment of Phage and Antibiotic Combination Therapy of a Multi-Drug Resistant <i>Pseudomonas aeruginosa</i> Murine Model
Background: Pseudomonas aeruginosa (PsA) is a common etiology of bacteria-mediated lower respiratory tract infections, including pneumonia, hospital acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP). Given the paucity of novel antibiotics in our foreseeable pipeline, developing nov...
Main Authors: | Christopher Duplessis, Jonathan M. Warawa, Matthew B. Lawrenz, Matthew Henry, Biswajit Biswas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/8/946 |
Similar Items
-
Aztreonam Lysine Increases the Activity of Phages E79 and phiKZ against <i>Pseudomonas aeruginosa</i> PA01
by: Carly M. Davis, et al.
Published: (2021-01-01) -
Phage Biocontrol of <i>Pseudomonas aeruginosa</i> in Water
by: Ari Kauppinen, et al.
Published: (2021-05-01) -
The Efficacy of Phage Therapy in a Murine Model of Pseudomonas aeruginosa Pneumonia and Sepsis
by: Xu Yang, et al.
Published: (2021-07-01) -
Novel Bacteriophages Show Activity against Selected Australian Clinical Strains of <i>Pseudomonas aeruginosa</i>
by: Samuel Namonyo, et al.
Published: (2022-01-01) -
Synergistic Killing and Re-Sensitization of <i>Pseudomonas aeruginosa</i> to Antibiotics by Phage-Antibiotic Combination Treatment
by: Emily Engeman, et al.
Published: (2021-02-01)